世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000042569

生物製剤製造市場規模、シェア、動向分析レポート:セグメント予測、2025‐2033

Grand View Research Inc.

Biologics Manufacturing Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2025- 2033

発刊日 2025/09

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000042569

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

規模、シェア、動向分析レポート:製造モード別 (受託、社内)、モダリティ別、疾患 適応症別、地域別、およびセグメント予測、2025- 2033

生物製剤製造市場の概要

世界のバイオ医薬品製造の市場規模は、2024年に334.8億ドルと推定され、2025年から2033年にかけて年平均成長率17.0%で成長し、2033年には1,406.2億ドルに達すると予測されます。この成長は、主にバイオ医薬品の需要増加、バイオ医薬品生産能力の拡大、細胞および遺伝子治療製造技術の進歩によって推進されています。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Mode
1.2.2. Modality
1.2.3. Disease Indication
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Impact Analysis
3.3.1.1. Rising burden of chronic disease
3.3.1.2. Growing Demand for Novel and Targeted Therapies
3.3.2. Market Restraint Impact Analysis
3.3.2.1. High Manufacturing Costs and Capital Intensity
3.3.2.2. Complex Regulatory and Quality Compliance
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. PORTER’S Five Forces Analysis

Chapter 4. Mode Business Analysis
4.1. Mode Segment Dashboard
4.2. Global Biologics Manufacturing Market Mode, Movement Analysis
4.3. Global Biologics Manufacturing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
4.4. Contract Manufacturing
4.4.1. Global contract manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
4.5. In-house manufacturing
4.5.1. Global In-house manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Modality Business Analysis
5.1. Modality Segment Dashboard
5.2. Global Biologics Manufacturing Market Modality, Movement Analysis
5.3. Global Biologics Manufacturing Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
5.4. Monoclonal Antibodies (mAbs)
5.4.1. Global monoclonal antibodies (mAbs) market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Biosimilar & Recombinant Proteins
5.5.1. Global biosimilar & recombinant proteins market estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Vaccines (recombinant/mRNA/Viral)
5.6.1. Global vaccines (recombinant/mRNA/Viral) market estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Cell & Gene Therapies
5.7.1. Global cell & gene therapies market estimates and forecasts, 2021 - 2033 (USD Million)
5.8. RNA-based Therapeutics
5.8.1. Global RNA-based therapeutics market estimates and forecasts, 2021 - 2033 (USD Million)
5.9. Others
5.9.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Disease Indication Business Analysis
6.1. Disease Indication Segment Dashboard
6.2. Global Biologics Manufacturing Market Disease Indication, Movement Analysis
6.3. Global Biologics Manufacturing Market Size & Trend Analysis, by Disease Indication, 2021 to 2033 (USD Million)
6.4. Oncology
6.4.1. Global Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Autoimmune Disorders
6.5.1. Global autoimmune disorders market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Infectious Diseases
6.6.1. Global infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Neurological Disorders
6.7.1. Global neurological disorders market estimates and forecasts, 2021 - 2033 (USD Million)
6.8. Cardiovascular Disorders
6.8.1. Global cardiovascular disorders market estimates and forecasts, 2021 - 2033 (USD Million)
6.9. Others Disease Indications
6.9.1. Global other disease indications market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Biologics Manufacturing Market: Regional Estimates and Trend Analysis, by Product, Mode, & Disease Indication,
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America biologics manufacturing market, 2021 - 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. U.S. biologics manufacturing market, 2021 - 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Canada biologics manufacturing market, 2021 - 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Mexico biologics manufacturing market, 2021 - 2033 (USD Million)
7.4. Europe
7.4.1. Europe biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. UK biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Germany biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. France biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Italy biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Spain biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Denmark biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Sweden biologics manufacturing market, 2021 - 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.4.9.5. Norway biologics manufacturing market, 2021 - 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Japan biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. China biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. India biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.5. Singapore
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Singapore biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Regulatory Framework
7.5.6.5. Australia biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. Regulatory Framework
7.5.7.5. Thailand biologics manufacturing market, 2021 - 2033 (USD Million)
7.5.8. South Korea
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Competitive Scenario
7.5.8.4. Regulatory Framework
7.5.8.5. South Korea biologics manufacturing market, 2021 - 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America biologics manufacturing market, 2021 - 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. Brazil biologics manufacturing market, 2021 - 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Argentina biologics manufacturing market, 2021 - 2033 (USD Million)
7.7. MEA
7.7.1. MEA biologics manufacturing market, 2021 - 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Regulatory Framework
7.7.2.5. South Africa biologics manufacturing market, 2021 - 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.7.3.5. Saudi Arabia biologics manufacturing market, 2021 - 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. Regulatory Framework
7.7.4.5. UAE biologics manufacturing market, 2021 - 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Regulatory Framework
7.7.5.5. Kuwait biologics manufacturing market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Novartis AG
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Pfizer Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Amgen Inc
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Novo Nordisk A/S
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. AbbVie Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Bristol-Myers Squibb Company
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Eli Lilly and Company
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. F. Hoffmann La-Roche Ltd.
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Wuxi Biologics
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. FUJIFILM Holdings Corporation (FUJIFILM Diosynth Biotechnologies)
8.4.11.1. Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Boehringer Ingelheim International GmbH
8.4.12.1. Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Lonza
8.4.13.1. Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Samsung Biologics
8.4.14.1. Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 4. Global Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 5. Global Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 6. Global Biologics Manufacturing Market, by Region, 2021 - 2033 (USD Million)
Table 7. North America Biologics Manufacturing Market, by Country, 2021 - 2033 (USD Million)
Table 8. North America Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 9. North America Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 10. North America Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 11. U.S. Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 12. U.S. Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 13. U.S. Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 14. U.S. Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 15. Canada Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 16. Canada Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 17. Canada Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 18. Canada Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 19. Mexico Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 20. Mexico Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 21. Mexico Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 22. Mexico Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 23. Europe Biologics Manufacturing Market, by Country, 2021 - 2033 (USD Million)
Table 24. Europe Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 25. Europe Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 26. Europe Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 27. Europe Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 28. Germany Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 29. Germany Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 30. Germany Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 31. Germany Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 32. UK Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 33. UK Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 34. UK Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 35. UK Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 36. France Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 37. France Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 38. France Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 39. France Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 40. Italy Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 41. Italy Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 42. Italy Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 43. Italy Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 44. Spain Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 45. Spain Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 46. Spain Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 47. Spain Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 48. Denmark Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 49. Denmark Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 50. Denmark Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 51. Denmark Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 52. Norway Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 53. Norway Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 54. Norway Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 55. Norway Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 56. Sweden Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 57. Sweden Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 58. Sweden Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 59. Sweden Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 60. Asia Pacific Biologics Manufacturing Market, by Country, 2021 - 2033 (USD Million)
Table 61. Asia Pacific Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 62. Asia Pacific Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 63. Asia Pacific Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 64. Asia Pacific Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 65. China Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 66. China Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 67. China Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 68. China Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 69. Japan Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 70. Japan Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 71. Japan Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 72. Japan Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 73. India Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 74. India Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 75. India Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 76. India Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 77. South Korea Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 78. South Korea Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 79. South Korea Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 80. South Korea Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 81. Australia Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 82. Australia Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 83. Australia Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 84. Australia Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 85. Thailand Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 86. Thailand Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 87. Thailand Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 88. Thailand Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 89. Latin America Biologics Manufacturing Market, by Country, 2021 - 2033 (USD Million)
Table 90. Latin America Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 91. Latin America Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 92. Latin America Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 93. Latin America Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 94. Brazil Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 95. Brazil Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 96. Brazil Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 97. Brazil Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 98. Argentina Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 99. Argentina Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 100. Argentina Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 101. Argentina Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 102. Middle East and Africa Biologics Manufacturing Market, by Country, 2021 - 2033 (USD Million)
Table 103. Middle East and Africa Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 104. Middle East and Africa Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 105. Middle East and Africa Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 106. Middle East and Africa Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 107. South Africa Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 108. South Africa Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 109. South Africa Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 110. South Africa Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 111. Saudi Arabia Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 112. Saudi Arabia Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 113. Saudi Arabia Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 114. Saudi Arabia Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 115. UAE Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 116. UAE Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 117. UAE Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 118. UAE Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)
Table 119. Kuwait Biologics Manufacturing Market, by Product, 2021 - 2033 (USD Million)
Table 120. Kuwait Biologics Manufacturing Market, by Mode, 2021 - 2033 (USD Million)
Table 121. Kuwait Biologics Manufacturing Market, by Modality, 2021 - 2033 (USD Million)
Table 122. Kuwait Biologics Manufacturing Market, by Disease Indication, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Biologics manufacturing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validation & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Competitive landscape snapshot
Fig. 15 Market trends & outlook
Fig. 16 PESTEL analysis
Fig. 17 Porter’s five forces analysis
Fig. 18 Biologics manufacturing market: Mode outlook key takeaways
Fig. 19 Biologics manufacturing market: Mode movement analysis
Fig. 20 Contract manufacturing market, 2021 - 2033 (USD Million)
Fig. 21 In-house manufacturing market, 2021 - 2033 (USD Million)
Fig. 22 Biologics manufacturing market: Modality outlook key takeaways
Fig. 23 Biologics manufacturing market: Modality movement analysis
Fig. 24 Monoclonal antibodies (mAbs)market, 2021 - 2033 (USD Million)
Fig. 25 Biosimilar & recombinant proteins market, 2021 - 2033 (USD Million)
Fig. 26 Vaccines (recombinant/mRNA/Viral) market, 2021 - 2033 (USD Million)
Fig. 27 Cell & gene therapies market, 2021 - 2033 (USD Million)
Fig. 28 RNA-based therapeutics market, 2021 - 2033 (USD Million)
Fig. 29 Others market, 2021 - 2033 (USD Million)
Fig. 30 Biologics manufacturing market: Disease Indication outlook key takeaways
Fig. 31 Biologics manufacturing market: Disease Indication movement analysis
Fig. 32 Oncology market, 2021 - 2033 (USD Million)
Fig. 33 Autoimmune disorders market, 2021 - 2033 (USD Million)
Fig. 34 Infectious diseases market, 2021 - 2033 (USD Million)
Fig. 35 Neurological disorders market, 2021 - 2033 (USD Million)
Fig. 36 Cardiovascular disorders market, 2021 - 2033 (USD Million)
Fig. 37 Other disease indications market, 2021 - 2033 (USD Million)
Fig. 38 Regional marketplace outlook, 2024 & 2033 (USD Million)
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 U.S. biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Canada biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Mexico biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 Europe biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Germany biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 UK biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 France biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Italy biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Spain biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Denmark biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Sweden biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Norway biologics manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 64 Asia Pacific biologics manufacturing market estimates and forecast, 2021 - 2033, (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Japan biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 China biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 India biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 South Korea biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Australia biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Thailand biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Latin America biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Brazil biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Argentina biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 82 MEA biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 South Africa biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Saudi Arabia biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 UAE biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Kuwait biologics manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 91 Market position analysis
Fig. 92 Market participant categorization
Fig. 93 Strategic framework

この商品のレポートナンバー

0000042569

TOP